Skip to main content
. 2022 Mar 8;5(3):e221480. doi: 10.1001/jamanetworkopen.2022.1480

Table 1. Characteristics of Patients Seen During Study Time Periods.

Characteristic Patients, No. (%)
All patients (n = 23 026) Time period
Before tablet (n = 12 239) After tablet (n = 10 787)
Sex
Female 13 342 (57.9) 7030 (57.4) 6312 (58.5)
Male 9684 (42.1) 5209 (42.6) 4475 (41.5)
Age, mean (range), y 59.7 (18-102) 60.2 (18-102) 59.0 (18-102)
Race and ethnicity
Asian 324 (1.4) 161 (1.3) 163 (1.5)
Black/African American 3098 (13.5) 1640 (13.4) 1458 (13.5)
Hispanic or Latino 745 (3.2) 388 (3.2) 357 (3.3)
White, non-Hispanic 18 542 (80.5) 9876 (80.7) 8666 (80.3)
Othera 317 (1.4) 174 (1.4) 143 (1.3)
Primary health insurance
Commercial 10 344 (44.9) 5382 (44.0) 4962 (46.0)
Medicaid 778 (3.4) 401 (3.3) 377 (3.5)
Medicare 10 522 (45.7) 5705 (47.6) 4817 (44.7)
Uninsured 829 (3.6) 462 (3.8) 367 (3.4)
Other 553 (2.3) 289 (2.4) 264 (2.4)
Practice
A 3665 (15.9) 1935 (15.8) 1730 (16.0)
B 3442 (14.9) 1574 (12.9) 1868 (17.3)
C 3820 (16.6) 1943 (15.9) 1877 (17.4)
Db 4739 (20.6) 2866 (23.4) 1873 (17.4)
E 4385 (19.0) 2215 (18.1) 2170 (20.1)
Fb 2975 (12.9) 1706 (13.9) 1269 (11.8)
a

Other race and ethnicity categories included American Indian or Alaska Native, Hawaiian or Other Pacific Islander, Other, and Unknown.

b

The period of observation following implementation at the practice was truncated at 30 days because of the COVID-19 pandemic.